Search Results 1191-1200 of 20412 for hepatitis

  1. Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery - Mayo Clinic

    Active, uncontrolled infection, including hepatitis B, hepatitis C; Concurrent anti-cancer therapy, including chemotherapy agents, targeted agents, or ...

  2. Medical Research & Education - Mayo Clinic News Network

    ... hepatitis. Jay Furst. February 15, 2022. Research. Regenerative Medicine Minnesota awards 5 research grants to Mayo Clinic. Mayo Clinic Staff. February 15, 2022.

  3. Healthcare Delivery - 2022 Archives - Mayo Clinic News Network

    Hepatitis B Immunity Check Needed for Newly Diagnosed Celiac Disease? Mayo Clinic Staff. January 25, 2022. Science Saturday: Improving implementation of ...

  4. Living-donor kidney transplant - Doctors & Departments - Mayo Clinic

    ... hepatitis, Liver cancer, Fatty liver disease, End-stage liver disease ... , Hepatitis C, Blood type incompatibility. Show more areas of focus for Andrew ...

  5. Allogeneic Transplant in HIV Patients (BMT CTN 0903) - Mayo Clinic

    Concomitant Hepatitis - Patients with chronic hepatitis B or C may be enrolled on the trial providing the above bilirubin and transaminase criteria are met.

  6. Study To Evaluate Efficacy And Safety Of Mepolizumab For Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients - Mayo Clinic

    Chronic stable hepatitis B and C are acceptable if subject otherwise meets entry criteria (e.g. presence of hepatitis B surface antigen or positive hepatitis C ...

  7. A Study of Human Stem Cells from First Teeth in Humans - Mayo Clinic

    Patients with past history or present condition of HIV, Hepatitis A, B, C. Participating Mayo Clinic locations. Study statuses change often. Please contact ...

  8. Breast Clinic - Clinical trials

    In traditional Chinese medicine, it is used for enhancing function and removing toxins, as well as for cancer, hepatitis, and infections. There is previous ...

  9. A Study of the Safety and Drug/Body Interactions of LAM-002A for Patients with Non-Hodgkin's Lymphoma - Mayo Clinic

    ... hepatitis B or hepatitis C; Is lactating and breast feeding; Unable or unwilling to abide by the study protocol or cooperate fully with the Investigator or ...

  10. A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy - Mayo Clinic

    Known Human Immunodeficiency Virus (HIV), active Hepatitis B Virus (HBV), and/or active Hepatitis C Virus (HCV) infection. Prior therapy with lenalidomide ...